检索结果 - Miravitlles, M

Actualización de las recomendaciones ALAT sobre la neumonía adquirida en la comunidad 由 Miravitlles, M.

获取全文 获取全文

Costes directos de la bronquitis crónica en atención primaria. Análisis de un estudio prospectivo 由 Miravitlles, M.

获取全文 获取全文 获取全文

Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients? 由 Blasi, F., Canonica, G. W., Miravitlles, M.

获取全文 获取全文 获取全文

Erratum to: Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients? 由 Blasi, F., Canonica, G. W., Miravitlles, M.

获取全文 获取全文 获取全文

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD 由 Brusasco, V, Hodder, R, Miravitlles, M, Korducki, L, Towse, L, Kesten, S

获取全文 获取全文 获取全文

Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD 由 Brusasco, V, Hodder, R, Miravitlles, M, Korducki, L, Towse, L, Kesten, S

获取全文 获取全文 获取全文

Alpha‐1‐antitrypsin deficiency: optimal therapeutic regimen based on population pharmacokinetics 由 Soy, D, de la Roza, C, Lara, B, Esquinas, C, Torres, A, Miravitlles, M

获取全文 获取全文 获取全文

Characterization of specific immunoglobulin G (IgG) and its subclasses (IgG1 and IgG2) against the 23-valent pneumococcal vaccine in a healthy adult population: proposal for respon... 由 Rodrigo, M J, Miravitlles, M, Cruz, M J, de Gracia, J, Vendrell, M, Pascual, C, Morell, F

获取全文 获取全文

Screening for polymorphisms in exon 5 of the glutathione S-transferase Pl gene 由 RODRIGUEZ-FRIAS, F., GONZALEZ, C., COSTA, X., CAMPOS, F., COTRINA, M., JARDI, R., MIRAVITLLES, M., VIDAL, R., ISHII, T., TERAMOTO, S., MATSUSE, T.

获取全文 获取全文 获取全文

Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study 由 Miravitlles, M, Ferrer, M, Pont, A, Zalacain, R, Alvarez-Sala, J, Masa, F, Verea, H, Murio, C, Ros, F, Vidal, R

获取全文 获取全文 获取全文

Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease:... 由 Driessen, M. T., Whalen, J., Seewoodharry Buguth, B., Vallejo-Aparicio, L. A., Naya, I. P., Asukai, Y., Alcázar-Navarrete, B., Miravitlles, M., García-Río, F., Risebrough, N. A.

获取全文 获取全文 获取全文

Correction to: Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulm... 由 Driessen, M. T., Whalen, J., Buguth, B. Seewoodharry, Vallejo-Aparicio, L. A., Naya, I. P., Asukai, Y., Alcázar-Navarrete, B., Miravitlles, M., García-Río, F., Risebrough, N. A.

获取全文 获取全文 获取全文